Citations

Clear

42 citation(s) found for "Couper, D".

Associations of Pre-pandemic Spirometry With COVID-19 Hospitalization or Death: The Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study
Rusk, A.M., Bowler, R.P., Elkind, Mitchell S, Kaplan, Robert C. , Lee, J.S., Ramachandran, V., Woodruff, Prescott G. , McKleroy, William , Garudadri, S., Ortega, Victor E. , Balte, Pallavi , Allen, Norrina B. , Barr, R. Graham , Cole, Shelley A. , Couper, David , Demmer, Ryan T. , Doyle, Margaret F. , Post, Wendy S. , Ramachandran, V., Schwartz, David A. , Tracy, Russell P. , Wenzel, Sally E. , Xanthakis, Vanessa , Oelsner, Elizabeth C.

Mayo Clinic

C46. CLINICAL AND PHYSIOLOGIC METRICS OF RESPIRATORY DISEASE AND COPD: FROM DIAGNOSIS TO PROGNOSIS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5733-A5733

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5733 Get It

Computer Assisted Quantitative Image Analysis as a Pathway to Identification of Combined Pulmonary Fibrosis and Emphysema (CPFE): Analysis of the SPIROMICS Cohort
HOESTEREY, DANIEL , Kim, G.H.J., Lee, Jungmin , Pourzand, Lila , Oh, Andrea , Bateman, Lori A. , Cooper, C.B., Hansel, Nadia N. , Kim, V., Ortega, Victor E. , Paine, Robert , Peters, Stephen P. , Wang, J.M., Woodruff, Prescott G. , Abtin, F., Tashkin, Donald P. , Hoffman, Eric A. , Barr, R. Graham , Bowler, Russell P. , Cooper, C.B. , Couper, David , Curtis, Jeffrey L. , Dransfield, Mark T. , Drummond, Michael , Han, MeiLan King , Kaner, Robert J. , Krishnan, Jerry A , Martínez, Fernando J. , Reinhardt, Joseph M. , Wells, J. Michael , Goldin, Jonathan , Abtin, Fereidoun G. , Barjaktarević, Igor

Mayo Clinic

C24. CLINICAL, BIOLOGIC, AND RADIOLOGIC MARKERS OF KEY OUTCOMES AND TREATMENT RESPONSE IN COPD | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5118-A5118

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5118 Get It

Associations of COPD and Related Outcomes With COVID-19 Hospitalization or Death: The C4R, Copdgene, and Spiromics Studies
Rusk, A.M., Bowler, R.P., Margaret, D., Elkind, Mitchell S.V. , Ramachandran, V., Woodruff, Prescott G. , Garudadri, S., McKleroy, William , Ortega, Victor E. , Balte, Pallavi , Allen, Norrina B. , Barr, R. Graham , Regan, Elizabeth Anne , Cole, Shelley A. , Couper, David , Demmer, Ryan T. , Kaplan, Robert C. , Lee, Joyce , Post, Wendy S. , Ramachandran, V., Schwartz, David A. , Tracy, Russell P. , Wenzel, Sally E. , Xanthakis, Vanessa , Make, Barry J. , Oelsner, Elizabeth C.

Mayo Clinic

C107. MICROBIAL RESPIRATORY INFECTIONS DISCOVERIES | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A6817-A6817

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6817 Get It

Effects of hearing intervention on cognitive decline: Results of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized trial
Lin, Frank R. , Albert, Marilyn S. , Burgard, Sheila , Gmelin, Theresa , Gravens‐Mueller, Lisa, Huang, Alison , Mosley, Thomas H., Reed, Nicholas S. , Windham, B. Gwen , Pike, James Russell , Arnold, Michelle L. , Chisolm, Theresa Hnath , Couper, David , Deal, Jennifer A. , Goman, Adele M. , Glynn, Nancy W. , Hayden, Kathleen M. , Knopman, David S. , MITCHELL, CHRISTINE M. , Pankow, James S. , Sanchez, Victoria A , Schrack, Jennifer A. , Coresh, Josef

Mayo Clinic

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S24 | Pages: No page available

10.1002/alz.083084 Get It

AbstractBackgroundHearing loss is associated with greater cognitive decline and incident dementia. Whether hearing intervention could reduce cognitive decline in older adults with hearing loss is unknown.MethodThe ACHIEVE study is a randomized trial (NCT03243422) of 70‐84 year‐old adults with untreated hearing loss and free from substantial cognitive impairment that took place at four U.S. sites. Participants were recruited from two study populations: 1) a group of adults participating in a longstanding observational study of cardiovascular health (Atherosclerosis Risk in Communities [ARIC] study), and 2) a group of healthy de novo community volunteers. Participants were randomised (1:1) to hearing intervention (HI; audiological counseling and provision of hearing aids) or a successful aging health education control intervention (SA; sessions with a health educator on chronic disease prevention). The primary intention‐to‐treat endpoint was 3‐year change in a global cognition standardized factor score from a comprehensive neurocognitive battery.Result977 participants (238 ARIC, 739 de novo) underwent randomisation; 490 were assigned to HI and 487 to SA control. Participants from ARIC were older, had more risk factors for cognitive decline, and had lower baseline cognitive scores than the de novo group. In the primary analysis combining the ARIC and de novo groups, 3‐year cognitive change (in S.D. units) was not significantly different between HI and SA control (HI: ‐0·200 [95% CI: ‐0·256,‐0·144]; SA: ‐0·202 [‐0·258,‐0·145]; Difference 0·002 [‐0·077,0·081],p = 0·96). However, prespecified analyses demonstrated significant differences in the effect of HI on cognitive change between the ARIC and de novo group (p interaction = 0·010). In the ARIC group, HI was associated with a 48% reduction in 3‐year cognitive change compared to SA control (HI: ‐0·211 [‐0·349,‐0·073]; SA: ‐0·402 [‐0·536, ‐0·267]; Difference 0·191 [0·022,0·360,p = 0·027]). In the de novo group, cognitive change was not significantly different between HI and SA control (HI: ‐0·213 [‐0·277,‐0·148]; SA: ‐0·151 [‐0·215,‐0·087]; Difference ‐0·061 [‐0·151,0·028,p = 0·18]). The rate of cognitive change among control participants was observed to be 2.7‐fold faster in the ARIC versus de novo group.ConclusionHearing intervention may have a significant effect on reducing cognitive change over 3 years in populations of older adults at increased risk for cognitive decline.